This document discusses drug excretion pathways and mechanisms. It states that excretion involves the irreversible transfer of drugs and metabolites from the internal to external environment through renal and non-renal routes. The principal organs of excretion are the kidneys, bile, lungs, saliva, milk, and sweat. The kidneys are the primary route of excretion, utilizing glomerular filtration, tubular secretion, and reabsorption to eliminate compounds under 500 Da. Bile actively secretes hydrophilic drugs and metabolites over 500 Da, while the lungs passively diffuse gases and volatile substances.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
A brief presentation on the factors affecting bioavailability of drugs along with a quick overview on what is bioequivalence, clinical equivalence, therapeutic equivalence, chemical equivalence and pharmaceutical equivalence.
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
A brief presentation on the factors affecting bioavailability of drugs along with a quick overview on what is bioequivalence, clinical equivalence, therapeutic equivalence, chemical equivalence and pharmaceutical equivalence.
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...NarayanRajaramkote
INTRODUCTION
Excretion is defined as the process whereby drugs and/or their metabolites are irreversibly transferred from internal to external environment.
Excretion of unchanged or intact drug is important in the termination of its pharmacological action.
The principal organs of excretion are kidneys. Excretion of drug by kidneys is called as renal excretion.
Excretion by organs other than kidneys such as lungs, biliary system, intestine, salivary glands and sweat glands is known as nonrenal excretion. Almost all drugs and their metabolites are excreted by the kidneys to some extent or the other.
Some drugs such as gentamicin are exclusively eliminated by renal route only.
Agents that are excreted in urine are –
1. Water-soluble.
2. Non-volatile.
3. Small in molecular size (less than 500 Daltons).
4. The ones that are metabolised slowly
The basic functional unit of kidney involved in excretion is the nephron. Each kidney comprises of one million nephrons.
Each nephron is made up of the glomerulus, the proximal tubule, the loop of Henle, the distal tubule and the collecting tubule.
Glomerular Filtration :
Glomerular filtration is a non-selective, unidirectional process whereby most compounds, ionised or unionised, are filtered except those that are bound to plasma proteins or blood cells and thus behave as macromolecules.
The driving force for filtration through the glomerulus is the hydrostatic pressure of the blood flowing in the capillaries. Out of the 25% of cardiac output or 1.2 litres of blood/min that goes to the kidneys via renal artery, only 10% or 120 to 130 ml/min is filtered through the glomeruli, the rate being called as the glomerular filtration rate (GFR).
The GFR can be determined by an agent that is excreted exclusively by filtration and is neither secreted nor reabsorbed in the tubules. The excretion rate value of such an agent is 120 to 130 ml/min. Creatinine, inulin, mannitol and sodium thiosulphate are used to estimate GFR of which the former two are widely used to estimate renal function.
Pharmacokinetics is the study of the movement of drug molecules in the body. It includes absorption, distribution, metabolism, and excretion of drugs. Pharmacokinetics is the study of what happens to drugs once they enter the body (the movement of the drugs into, within, and out of the body). For a drug to produce its specific response, it should be present in adequate concentrations at the site of action. This depends on various factors apart from the dose.
Four pharmacokinetic properties determine the onset, intensity, and the duration of drug action (Figure 1.6.1):
• Absorption: First, absorption from the site of administration permits entry of the drug (either directly or indirectly) into plasma.
• Distribution: Second, the drug may then reversibly leave the bloodstream and distribute it into the interstitial and intracellular fluids.
• Metabolism: Third, the drug may be biotransformed by metabolism by the liver or other tissues.
• Elimination: Finally, the drug and its metabolites are eliminated from the body in urine, bile, or feces.
In short, pharmacokinetics means what the body does to the drug.
Non renal routes of excretion For pharmacy studentsLokesh Patil
Non-renal routes of excretion are those by which metabolites and medications are removed from the body by means of systems other than the kidneys. Two such pathways are pulmonary excretion, which expels volatile chemicals via the lungs, and biliary excretion, which secretes molecules into the bile and excretes them in feces. Moreover, medications may be eliminated via saliva, perspiration, and breast milk. Whereas the respiratory route is important for gaseous anesthetics and alcohol, the liver is essential in the metabolism of medications for biliary excretion. Especially in individuals with compromised kidney function, controlling medication dosage and reducing toxicity need an understanding of these non-renal pathways.
This is the material for the 2nd week meeting on Food and Drugs Interaction for Nutrition students. This topic will cover the drug metabolism, looking at the pharmacokinetics and pharmacodynamics of drugs.
CNS Introduction, Neurons, Type of Neurons and functions, Neuroglia and types, Receptors and their types, Synapse, Neurotransmitters and their functions
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. Excretion is defined as a process whereby drugs
or metabolites are irreversibly transferred from
internal to external environment through renal
or non renal route.
Excretion, along with metabolism and tissue
redistribution, is important in determining both the
duration of drug action and the rate of drug
elimination.
5. Drugs are eliminated from the body primarily by
the kidneys.
The principal renal mechanisms that are involved in the
excretion of drugs are:
1. Glomerular filtration
2. Active tubular secretion
3. Active tubular reabsorption
6.
7. The ultrastructure of the glomerular capillary wall is
such that it permits a high degree of fluid filtration
while restricting the passage of compounds having
relatively large molecular weights.
This selective filtration is important in that it
prevents the filtration of plasma proteins (e.g.,
albumin) that are important for maintaining an
osmotic gradient in the vasculature and thus plasma
volume.
8. Several factors, including molecular size, charge, and
shape, influence the glomerular filtration of large
molecules.
As the ultrafiltrate is formed, any drug that is free in
the plasma water, that is, not bound to plasma
proteins or the formed elements in the blood (e.g., red
blood cells), will be filtered as a result of the driving
force provided by cardiac pumping.
9. All unbound drugs will be filtered as long as their
molecular size, charge, and shape are not excessively
large.
Compounds with 20 Å to 42Å may undergo
glomerular filtration.
10. The tubular secretion which is carried out at the level
of the proximal tubule is an active process.
It is carrier mediated process which requires energy
for transportation of compounds against conc.
gradient
Two secretion mechanisms are identified.
System for secretion of organic acids/anions
e.g. Penicillin, salicylates etc
System for organic base / cations
e.g. morphine, mecamylamine hexamethonium
11. Organic Anion Transport Organic Cation Transport
Acetazolamide Acetylcholine
Bile salts Atropine
Hydrochlorothiazide Cimetidine
Furosemide Dopamine
Indomethacin Epinephrine
Penicillin G Morphine
Prostaglandins Neostigmine
Salicylate Quinine
12. In the distal tubule there is passive excretion and re-
absorption of drugs. Drugs which are present in the
glomerular filtrate can be reabsorbed in the tubules. A
reason for this is that much of the water, in the
filtrate, has been reabsorbed and therefore the
concentration gradient is now in the direction of re-
absorption hence drug may be readily reabsorbed.
13. Many drugs are either weak bases or acids and
therefore the pH of the filtrate can greatly influence
the extent of tubular re-absorption for many drugs.
When urine is acidic, weak acid drugs tend to be
reabsorbed. Alternatively when urine is more
alkaline, weak bases are more extensively
reabsorbed. Making the urine more acidic can cause
less reabsorption of weak bases or enhanced
excretion.
14. In the case of a drug overdose it is possible to
increase the excretion of some drugs by suitable
adjustment of urine pH. For example, in the case of
pentobarbital (a weak acid) overdose it may be
possible to increase drug excretion by making the
urine more alkaline with sodium bicarbonate
injection.
15. Transporters are also present in the canalicular
membrane of the hepatocyte, and these actively
secrete drugs and metabolites into bile. e.g. the
organic anion transporting polypeptides (OATPs), the
P-glycoprotein transport system and the multidrug
resistance-associated proteins (Mrps). Drug in bile
enters the gastrointestinal tract after storage in the
gallbladder. It may then be excreted from the body by
the stools.
16. A drug excreted in bile may be reabsorbed from the
gastrointestinal tract or a drug conjugate may be
hydrolyzed by gut bacteria, liberating original drug
which can be returned to the general circulation.
Such recycling may continue (enterohepatic cycle or
circulation) until the drug either undergoes metabolic
changes in the liver, is excreted by the kidneys, or
both.
17. Such enterohepatic recycling, if extensive, may
prolong significantly the presence of a drug (or toxin)
and its effects within the body prior to elimination by
other pathways.
Orally administered activated charcoal and/or anion
exchange resins have been used clinically to interrupt
enterohepatic cycling and trap drugs in the
gastrointestinal tract.
Cholestatic disease states, in which normal bile flow
is reduced, will influence drug elimination by this
route resulting in increased risk of drug toxicity.
18. Gases and other volatile substances such as general
anesthetics that enter the body primarily through the
respiratory tract can be expected to be excreted by this
route.
No specialized transport systems are involved in the loss
of substances in expired air; simple diffusion across cell
membranes is predominant.
The rate of loss of gases is not constant; it depends on
the rate of respiration and pulmonary blood flow.
19. The degree of solubility of a gas in blood also will
affect the rate of gas loss.
Gases such as nitrous oxide, which are not very
soluble in blood, will be excreted rapidly, that is,
almost at the rate at which the blood delivers the drug
to the lungs.
Ethanol, which has a relatively high blood gas
solubility, is excreted very slowly by the lungs.
20. The pH of saliva varies from 5.8 to 8.4. Unionized
lipid soluble drugs are excreted passively.
The bitter taste in the mouth of a patient is
indication of drug excreted. Some basic drugs inhibit
saliva secretion and are responsible for mouth dryness.
Compounds excreted in saliva are Caffeine,
Phenytoin, Theophylline.
21. Milk consists of lactic secretions which is rich in fats
and proteins.
Excretion of drug in milk is important as it gains
entry in breast feeding infants.
pH of milk varies from 6.4 to 7.6. Free un-ionized
and lipid soluble drugs diffuse passively.
Highly plasma bound drug like Diazepam is less
secreted in milk.
22. Amount of drug excreted in milk is less than 1% and
fraction consumed by infant is too less to produce
toxic effects. Some potent drugs like barbiturates and
morphine may induce toxicity.
23. Drugs excreted through skin via sweat follows pH
partition hypothesis. Excretion of drugs through skin
may lead to urticaria and dermatitis. Compounds like
benzoic acid, salicylic acid, alcohol and heavy metals
like lead, mercury and arsenic are excreted in sweat.
24. EXCRETION PATHWAYS, TRANSPORT
MECHANISMS & DRUG EXCRETED.
Excretory
route
Mechanism Drug Excreted
Urine GF, ATS, PTR Free, hydrophilic, unchanged drugs/
metabolites of MW< 300
Bile Active secretion Hydrophilic, unchanged drugs/
metabolites/ conjugates of MW >500
Lung Passive diffusion Gaseous &volatile, blood & tissue
insoluble drugs
saliva Passive diffusion
Active transport
Free, unionized, lipophilic drugs. Some
polar drugs
Milk Passive diffusion Free, unionized, lipophilic drugs (basic)
Sweat Passive diffusion Free, unionized lipophilic drugs